Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [906]
News [2550]
Articles [106]
Editorials [3]
Conferences [84]
elearning [20]
EXPLORER expands dynamic PET imaging ability to visualise dual blood supply in lung cancer
EXPLORER expands dynamic PET imaging ability to visualise dual blood supply in lung cancer
Artificial intelligence blood test provides a reliable way to identify lung cancer
Artificial intelligence blood test provides a reliable way to identify lung cancer
ASCO 2024: Trial reveals benefits of ‘stepped’ palliative care for patients with advanced lung cancer
ASCO 2024: Trial reveals benefits of ‘stepped’ palliative care for patients with advanced lung cancer
ASCO 2024: Telehealth as effective as in-person care for early palliative treatment in patients with advanced lung cancer
ASCO 2024: Telehealth as effective as in-person care for early palliative treatment in patients with advanced lung...
ASCO 2024: Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal cancer
ASCO 2024: Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal...
ASCO 2024: Durvalumab following chemoradiotherapy improved survival in patients with limited-stage small-cell lung cancer
ASCO 2024: Durvalumab following chemoradiotherapy improved survival in patients with limited-stage small-cell lung...
ASCO 2024: Osimertinib poised to change standard of care treatment for patients with locally advanced EGFR-mutated NSCLC
ASCO 2024: Osimertinib poised to change standard of care treatment for patients with locally advanced EGFR-mutated...
ASCO 2024: New study details longest progression-free survival ever reported in advanced NSCLC
ASCO 2024: New study details longest progression-free survival ever reported in advanced NSCLC
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer
Gene cluster expression index and potential indications for targeted therapy and immunotherapy for lung cancers
Gene cluster expression index and potential indications for targeted therapy and immunotherapy for lung cancers

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation